Feedback / Questions
DOC1021 - Diakonos Research
https://www.businesswire.com/news/home/20240409131379/en/Diakonos-Oncology%E2%80%99s-Unique-Dendritic-Cell-Vaccine-DOC1021-Improves-Survival-Compared-to-Standard-of-Care-in-Phase-1-Trial-for-Glioblastoma
Apr 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next